In our study, PI3K inhibition treatment significantly reduced aortic macrophage infiltration while suppressing AAA formation and progression, as the CD68 + macrophages in Wortmannin group is less than the Vehicle one. The gene discussed is CD68; the disease is triple-A syndrome.